DOCSLIB.ORG

The UBE2L3 Ubiquitin Conjugating Enzyme: Interplay with Inflammasome Signalling and Bacterial Ubiquitin Ligases

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The UBE2L3 Ubiquitin Conjugating Enzyme: Interplay with Inflammasome Signalling and Bacterial Ubiquitin Ligases The UBE2L3 ubiquitin conjugating enzyme: interplay with inflammasome signalling and bacterial ubiquitin ligases Matthew James George Eldridge 2018 Imperial College London Department of Medicine Submitted to Imperial College London for the degree of Doctor of Philosophy 1 Abstract Inflammasome-controlled immune responses such as IL-1β release and pyroptosis play key roles in antimicrobial immunity and are heavily implicated in multiple hereditary autoimmune diseases. Despite extensive knowledge of the mechanisms regulating inflammasome activation, many downstream responses remain poorly understood or uncharacterised. The cysteine protease caspase-1 is the executor of inflammasome responses, therefore identifying and characterising its substrates is vital for better understanding of inflammasome-mediated effector mechanisms. Using unbiased proteomics, the Shenoy grouped identified the ubiquitin conjugating enzyme UBE2L3 as a target of caspase-1. In this work, I have confirmed UBE2L3 as an indirect target of caspase-1 and characterised its role in inflammasomes-mediated immune responses. I show that UBE2L3 functions in the negative regulation of cellular pro-IL-1 via the ubiquitin- proteasome system. Following inflammatory stimuli, UBE2L3 assists in the ubiquitylation and degradation of newly produced pro-IL-1. However, in response to caspase-1 activation, UBE2L3 is itself targeted for degradation by the proteasome in a caspase-1-dependent manner, thereby liberating an additional pool of IL-1 which may be processed and released. UBE2L3 therefore acts a molecular rheostat, conferring caspase-1 an additional level of control over this potent cytokine, ensuring that it is efficiently secreted only in appropriate circumstances. These findings on UBE2L3 have implications for IL-1- driven pathology in hereditary fever syndromes, and autoinflammatory conditions associated with UBE2L3 polymorphisms. 2 Acknowledgments First and foremost, I would like to extend my most sincere thanks to my supervisor Avinash. Having the opportunity to join a brand-new lab has taught me so many things at and away from the bench and being able to learn from you first hand has been invaluable. Not every student gets the opportunity to work so closely with their supervisor and I will be forever grateful for your mentorship. I would like to thank my lab mates Julia and Pippa, you two have been the best lab mates ever. Thank you for always being around, not only have you been great colleagues, you have been fantastic and supportive friends. Without the two of you, the 4th floor would have been a very different place, it was a pleasure working with you both. Julia, thank you for all your contributions to the paper, it would have taken three times as long without you. Thank you to the other inhabitants of the 4th floor, old and new Dan, Amy, Sophie, and Nancy, you couldn’t ask for better people to share a lab space with. Thank you to my supervisees who helped me with my bacteria side projects Anja, Youssef, and Razia. I would also like to thank all the members of the CMBI who I have crossed paths with over the years in particular Vani, Miles, Robbie, Sina, Agnes, Angie thank you for making it such a great place to work. Thank you Sanika, who entered the fray a little later but made the last year and half of my PhD that little bit easier. Finally, thank you to my parents, my sister and the rest of my family whose continued support has made my academic studies possible. Mum and Dad thank you for giving me the opportunity to pursue what I love to do. 3 Declaration of originality I hereby declare that the work presented in this thesis is my own, any work carried out by anyone other than myself be it published and unpublished has been acknowledged and clearly credited in the relevant figure legends. Any resources or ideas that are from the work of others has been reference and a full bibliography can be found at the end of this thesis. Copyright declaration The copyright of this thesis rests with the author and is made available under a Creative Commons Attribution Non-Commercial No Derivatives licence. Researchers are free to copy, distribute or transmit the thesis on the condition that they attribute it, that they do not use it for commercial purposes and that they do not alter, transform or build upon it. For any reuse or redistribution, researchers must make clear to others the licence terms of this work. 4 Table of contents Abstract ...................................................................................................................................... 2 Acknowledgments...................................................................................................................... 3 Declaration of originality ........................................................................................................... 4 Copyright declaration ................................................................................................................ 4 Tables and figures .................................................................................................................... 10 Abbreviations ........................................................................................................................... 15 Chapter 1 – Introduction ......................................................................................................... 18 1.1 Introduction to pattern recognition .............................................................................. 19 1.2 Toll-like receptor signalling ............................................................................................ 20 1.2.1 MyD88 dependent activation of NF-κB .................................................................. 22 1.2.2 TRIF dependent signalling ....................................................................................... 24 1.3 Inflammasomes .............................................................................................................. 25 1.3.1 Principles of inflammasome activation................................................................... 25 1.3.3 NLRP3 inflammasome ............................................................................................. 28 1.3.4 NLRC4 inflammasome ............................................................................................. 31 1.3.5 AIM2 inflammasome ............................................................................................... 33 1.3.6 Non-canonical inflammasome activation ............................................................... 34 1.3.7 PYRIN inflammasome .............................................................................................. 35 1.3.8 NLRP1 inflammasome ............................................................................................. 37 1.3.9 Other inflammasomes ............................................................................................ 38 1.4 Caspase-1 Substrates and Targets ................................................................................. 39 1.4.1 pro-IL-1β .................................................................................................................. 40 1.4.2 pro-IL-18 .................................................................................................................. 42 1.4.3 IL-1α ........................................................................................................................ 43 1.4.4 Gasdermin D ........................................................................................................... 44 1.5 Inflammasome signalling during bacterial infection ......................................................... 46 1.5.1 Pathogen sensing by inflammasomes .................................................................... 46 1.5.2 Bacterial circumvention of inflammasome sensing and mechanisms ................... 48 1.5.3 Host-protective properties of inflammasomes during bacterial infection ............. 49 1.6 Role of inflammasomes in inheritable illnesses ................................................................ 51 1.7 Novel downstream targets of inflammasomes ................................................................. 53 1.8 Enzymes of the ubiquitin cascade ..................................................................................... 55 5 1.9 UBE2L3: an atypical E2 conjugating enzyme ..................................................................... 58 1.10 Aims and Objectives ......................................................................................................... 63 Chapter 2 – Materials and Methods ....................................................................................... 64 2.1 Eukaryotic and bacterial cell growth conditions............................................................ 65 2.1.1 Eukaryotic cell culture ............................................................................................. 65 2.1.2 Bacterial growth conditions for infection ............................................................... 66 2.2 Bacterial strains, plasmids, and primers ........................................................................ 69 2.2.1 Bacterial strains ....................................................................................................... 69 2.2.2 Bacterial and eukaryotic expression plasmids ........................................................ 70 2.2.4 Primers used during this study ..............................................................................
Load more

Recommended publications
  • Versatile Roles of K63-Linked Ubiquitin Chains in Trafficking
    Cells 2014, 3, 1027-1088; doi:10.3390/cells3041027 OPEN ACCESS cells ISSN 2073-4409 www.mdpi.com/journal/cells Review Versatile Roles of K63-Linked Ubiquitin Chains in Trafficking Zoi Erpapazoglou 1,2, Olivier Walker 3 and Rosine Haguenauer-Tsapis 1,* 1 Institut Jacques Monod-CNRS, UMR 7592, Université-Paris Diderot, Sorbonne Paris Cité, F-75205 Paris, France; E-Mail: [email protected] 2 Current address: Brain and Spine Institute, CNRS UMR 7225, Inserm, U 1127, UPMC-P6 UMR S 1127, 75013 Paris, France 3 Institut des Sciences Analytiques, UMR5280, Université de Lyon/Université Lyon 1, 69100 Villeurbanne, France; E-Mail: [email protected] * Author to whom correspondence should be addressed; E-Mail: [email protected]. External Editor: Hanjo Hellmann Received: 14 July 2014; in revised form: 14 October 2014 / Accepted: 21 October 2014 / Published: 12 November 2014 Abstract: Modification by Lys63-linked ubiquitin (UbK63) chains is the second most abundant form of ubiquitylation. In addition to their role in DNA repair or kinase activation, UbK63 chains interfere with multiple steps of intracellular trafficking. UbK63 chains decorate many plasma membrane proteins, providing a signal that is often, but not always, required for their internalization. In yeast, plants, worms and mammals, this same modification appears to be critical for efficient sorting to multivesicular bodies and subsequent lysosomal degradation. UbK63 chains are also one of the modifications involved in various forms of autophagy (mitophagy, xenophagy, or aggrephagy). Here, in the context of trafficking, we report recent structural studies investigating UbK63 chains assembly by various E2/E3 pairs, disassembly by deubiquitylases, and specifically recognition as sorting signals by receptors carrying Ub-binding domains, often acting in tandem.
    [Show full text]
  • Molecular Profile of Tumor-Specific CD8+ T Cell Hypofunction in a Transplantable Murine Cancer Model
    Downloaded from http://www.jimmunol.org/ by guest on September 25, 2021 T + is online at: average * The Journal of Immunology , 34 of which you can access for free at: 2016; 197:1477-1488; Prepublished online 1 July from submission to initial decision 4 weeks from acceptance to publication 2016; doi: 10.4049/jimmunol.1600589 http://www.jimmunol.org/content/197/4/1477 Molecular Profile of Tumor-Specific CD8 Cell Hypofunction in a Transplantable Murine Cancer Model Katherine A. Waugh, Sonia M. Leach, Brandon L. Moore, Tullia C. Bruno, Jonathan D. Buhrman and Jill E. Slansky J Immunol cites 95 articles Submit online. Every submission reviewed by practicing scientists ? is published twice each month by Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts http://jimmunol.org/subscription Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html http://www.jimmunol.org/content/suppl/2016/07/01/jimmunol.160058 9.DCSupplemental This article http://www.jimmunol.org/content/197/4/1477.full#ref-list-1 Information about subscribing to The JI No Triage! Fast Publication! Rapid Reviews! 30 days* Why • • • Material References Permissions Email Alerts Subscription Supplementary The Journal of Immunology The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2016 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. This information is current as of September 25, 2021. The Journal of Immunology Molecular Profile of Tumor-Specific CD8+ T Cell Hypofunction in a Transplantable Murine Cancer Model Katherine A.
    [Show full text]
  • Nedd4 and Nedd4-2: Closely Related Ubiquitin-Protein Ligases with Distinct Physiological Functions
    Cell Death and Differentiation (2010) 17, 68–77 & 2010 Macmillan Publishers Limited All rights reserved 1350-9047/10 $32.00 www.nature.com/cdd Review Nedd4 and Nedd4-2: closely related ubiquitin-protein ligases with distinct physiological functions B Yang*,1 and S Kumar*,2 The Nedd4 (neural precursor cell-expressed developmentally downregulated gene 4) family of ubiquitin ligases (E3s) is characterized by a distinct modular domain architecture, with each member consisting of a C2 domain, 2–4 WW domains, and a HECT-type ligase domain. Of the nine mammalian members of this family, Nedd4 and its close relative, Nedd4-2, represent the ancestral ligases with strong similarity to the yeast, Rsp5. In Saccharomyces cerevisiae Rsp5 has a key role in regulating the trafficking, sorting, and degradation of a large number of proteins in multiple cellular compartments. However, in mammals the Nedd4 family members, including Nedd4 and Nedd4-2, appear to have distinct functions, thereby suggesting that these E3s target specific proteins for ubiquitylation. In this article we focus on the biology and emerging functions of Nedd4 and Nedd4-2, and review recent in vivo studies on these E3s. Cell Death and Differentiation (2010) 17, 68–77; doi:10.1038/cdd.2009.84; published online 26 June 2009 Ubiquitylation controls biological signaling in many different ubiquitin-protein ligase (E3). A protein can be monoubiquity- ways.1,2 For example, the ubiquitylation of a misfolded or lated, multi-monoubiquitylated, or polyubiquitylated, and the damaged protein leads to its degradation by the 26S type of ubiquitylation determines the fate of the protein.1,2 proteasome before it can get to its subcellular site where it Ubiquitin itself contains seven lysine residues, all of which can normally functions.
    [Show full text]
  • The Emerging Relevance of AIM2 in Liver Disease
    International Journal of Molecular Sciences Review The Emerging Relevance of AIM2 in Liver Disease Beatriz Lozano-Ruiz 1,2 and José M. González-Navajas 1,2,3,4,* 1 Alicante Institute for Health and Biomedical Research (ISABIAL), 03010 Alicante, Spain; [email protected] 2 Department of Pharmacology, Paediatrics and Organic Chemistry, University Miguel Hernández (UMH), 03550 San Juan, Alicante, Spain 3 Networked Biomedical Research Center for Hepatic and Digestive Diseases (CIBERehd), Institute of Health Carlos III, 28029 Madrid, Spain 4 Institute of Research, Development and Innovation in Healthcare Biotechnology in Elche (IDiBE), University Miguel Hernández, 03202 Elche, Alicante, Spain * Correspondence: [email protected]; Tel.: +34-(965)-913-928 Received: 16 August 2020; Accepted: 4 September 2020; Published: 7 September 2020 Abstract: Absent in melanoma 2 (AIM2) is a cytosolic receptor that recognizes double-stranded DNA (dsDNA) and triggers the activation of the inflammasome cascade. Activation of the inflammasome results in the maturation of inflammatory cytokines, such as interleukin (IL)-1 β and IL-18, and a form of cell death known as pyroptosis. Owing to the conserved nature of its ligand, AIM2 is important during immune recognition of multiple pathogens. Additionally, AIM2 is also capable of recognizing host DNA during cellular damage or stress, thereby contributing to sterile inflammatory diseases. Inflammation, either in response to pathogens or due to sterile cellular damage, is at the center of the most prevalent and life-threatening liver diseases. Therefore, during the last 15 years, the study of inflammasome activation in the liver has emerged as a new research area in hepatology. Here, we discuss the known functions of AIM2 in the pathogenesis of different hepatic diseases, including non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), hepatitis B, liver fibrosis, and hepatocellular carcinoma (HCC).
    [Show full text]
  • Laboratory Mouse Models for the Human Genome-Wide Associations
    Laboratory Mouse Models for the Human Genome-Wide Associations The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Kitsios, Georgios D., Navdeep Tangri, Peter J. Castaldi, and John P. A. Ioannidis. 2010. Laboratory mouse models for the human genome-wide associations. PLoS ONE 5(11): e13782. Published Version doi:10.1371/journal.pone.0013782 Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:8592157 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA Laboratory Mouse Models for the Human Genome-Wide Associations Georgios D. Kitsios1,4, Navdeep Tangri1,6, Peter J. Castaldi1,2,4,5, John P. A. Ioannidis1,2,3,4,5,7,8* 1 Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts, United States of America, 2 Tufts University School of Medicine, Boston, Massachusetts, United States of America, 3 Department of Hygiene and Epidemiology, University of Ioannina School of Medicine and Biomedical Research Institute, Foundation for Research and Technology-Hellas, Ioannina, Greece, 4 Tufts Clinical and Translational Science Institute, Tufts Medical Center, Boston, Massachusetts, United States of America, 5 Department of Medicine, Center for Genetic Epidemiology and Modeling, Tufts Medical Center, Tufts University
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Characterization of KRAS Rearrangements in Metastatic Prostate Cancer
    Published OnlineFirst April 3, 2011; DOI: 10.1158/2159-8274.CD-10-0022 ReseARcH BRieF characterization of KRAS rearrangements in Metastatic Prostate cancer Xiao-Song Wang 1– 3, * Sunita Shankar 1, 3, * Saravana M. Dhanasekaran 1, 3, * Bushra Ateeq 1, 3, Atsuo T. Sasaki 9, 10, Xiaojun Jing 1, 3, Daniel Robinson 1, 3, Qi Cao 1, 3, John R. Prensner 1, 3, Anastasia K. Yocum1, 3, Rui Wang, 1, 3 Daniel F. Fries 1, 3, Bo Han 1, 3, Irfan A. Asangani 1, 3, Xuhong Cao 1, 3, Yong Li 1, 3, Gilbert S. Omenn2 , Dorothee Pflueger 7, 8, Anuradha Gopalan 11, Victor E. Reuter 11, Emily Rose Kahoud 9, Lewis C. Cantley 9, 10, Mark A. Rubin 7, Nallasivam Palanisamy 1, 3, 6, Sooryanarayana Varambally 1, 3, 6, and Arul M. Chinnaiyan 1–6 ABstRAct Using an integrative genomics approach called amplification breakpoint ranking and assembly analysis, we nominated KRAS as a gene fusion with the ubiquitin- conjugating enzyme UBE2L3 in the DU145 cell line, originally derived from prostate cancer metas- tasis to the brain. Interestingly, analysis of tissues revealed that 2 of 62 metastatic prostate cancers harbored aberrations at the KRAS locus. In DU145 cells, UBE2L3-KRAS produces a fusion protein, a specific knockdown of which attenuates cell invasion and xenograft growth. Ectopic ex- pression of the UBE2L3-KRAS fusion protein exhibits transforming activity in NIH 3T3 fibroblasts and RWPE prostate epithelial cells in vitro and in vivo. In NIH 3T3 cells, UBE2L3-KRAS attenuates MEK/ERK signaling, commonly engaged by oncogenic mutant KRAS, and instead signals via AKT and p38 mitogen-activated protein kinase (MAPK) pathways.
    [Show full text]
  • The Ubiquitination Enzymes of Leishmania Mexicana
    The ubiquitination enzymes of Leishmania mexicana Rebecca Jayne Burge Doctor of Philosophy University of York Biology October 2020 Abstract Post-translational modifications such as ubiquitination are important for orchestrating the cellular transformations that occur as the Leishmania parasite differentiates between its main morphological forms, the promastigote and amastigote. Although 20 deubiquitinating enzymes (DUBs) have been partially characterised in Leishmania mexicana, little is known about the role of E1 ubiquitin-activating (E1), E2 ubiquitin- conjugating (E2) and E3 ubiquitin ligase (E3) enzymes in this parasite. Using bioinformatic methods, 2 E1, 13 E2 and 79 E3 genes were identified in the L. mexicana genome. Subsequently, bar-seq analysis of 23 E1, E2 and HECT/RBR E3 null mutants generated in promastigotes using CRISPR-Cas9 revealed that the E2s UBC1/CDC34, UBC2 and UEV1 and the HECT E3 ligase HECT2 are required for successful promastigote to amastigote differentiation and UBA1b, UBC9, UBC14, HECT7 and HECT11 are required for normal proliferation during mouse infection. Null mutants could not be generated for the E1 UBA1a or the E2s UBC3, UBC7, UBC12 and UBC13, suggesting these genes are essential in promastigotes. X-ray crystal structure analysis of UBC2 and UEV1, orthologues of human UBE2N and UBE2V1/UBE2V2 respectively, revealed a heterodimer with a highly conserved structure and interface. Furthermore, recombinant L. mexicana UBA1a was found to load ubiquitin onto UBC2, allowing UBC2- UEV1 to form K63-linked di-ubiquitin chains in vitro. UBC2 was also shown to cooperate with human E3s RNF8 and BIRC2 in vitro to form non-K63-linked polyubiquitin chains, but association of UBC2 with UEV1 inhibits this ability.
    [Show full text]
  • Proteomic Analysis Uncovers Measles Virus Protein C Interaction with P65
    bioRxiv preprint doi: https://doi.org/10.1101/2020.05.08.084418; this version posted May 9, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Proteomic Analysis Uncovers Measles Virus Protein C Interaction with p65/iASPP/p53 Protein Complex Alice Meignié1,2*, Chantal Combredet1*, Marc Santolini 3,4, István A. Kovács4,5,6, Thibaut Douché7, Quentin Giai Gianetto 7,8, Hyeju Eun9, Mariette Matondo7, Yves Jacob10, Regis Grailhe9, Frédéric Tangy1**, and Anastassia V. Komarova1, 10** 1 Viral Genomics and Vaccination Unit, Department of Virology, Institut Pasteur, CNRS UMR-3569, 75015 Paris, France 2 Université Paris Diderot, Sorbonne Paris Cité, Paris, France 3 Center for Research and Interdisciplinarity (CRI), Université de Paris, INSERM U1284 4 Network Science Institute and Department of Physics, Northeastern University, Boston, MA 02115, USA 5 Department of Physics and Astronomy, Northwestern University, Evanston, IL 60208-3109, USA 6 Department of Network and Data Science, Central European University, Budapest, H-1051, Hungary 7 Proteomics platform, Mass Spectrometry for Biology Unit (MSBio), Institut Pasteur, CNRS USR 2000, Paris, France. 8 Bioinformatics and Biostatistics Hub, Computational Biology Department, Institut Pasteur, CNRS USR3756, Paris, France 9 Technology Development Platform, Institut Pasteur Korea, Seongnam-si, Republic of Korea 10 Laboratory of Molecular Genetics of RNA Viruses, Institut Pasteur, CNRS UMR-3569,
    [Show full text]
  • E3 Ubiquitin Ligases: Key Regulators of Tgfβ Signaling in Cancer Progression
    International Journal of Molecular Sciences Review E3 Ubiquitin Ligases: Key Regulators of TGFβ Signaling in Cancer Progression Abhishek Sinha , Prasanna Vasudevan Iyengar and Peter ten Dijke * Department of Cell and Chemical Biology and Oncode Institute, Leiden University Medical Center, 2300 RC Leiden, The Netherlands; [email protected] (A.S.); [email protected] (P.V.I.) * Correspondence: [email protected]; Tel.: +31-71-526-9271 Abstract: Transforming growth factor β (TGFβ) is a secreted growth and differentiation factor that influences vital cellular processes like proliferation, adhesion, motility, and apoptosis. Regulation of the TGFβ signaling pathway is of key importance to maintain tissue homeostasis. Perturbation of this signaling pathway has been implicated in a plethora of diseases, including cancer. The effect of TGFβ is dependent on cellular context, and TGFβ can perform both anti- and pro-oncogenic roles. TGFβ acts by binding to specific cell surface TGFβ type I and type II transmembrane receptors that are endowed with serine/threonine kinase activity. Upon ligand-induced receptor phosphorylation, SMAD proteins and other intracellular effectors become activated and mediate biological responses. The levels, localization, and function of TGFβ signaling mediators, regulators, and effectors are highly dynamic and regulated by a myriad of post-translational modifications. One such crucial modification is ubiquitination. The ubiquitin modification is also a mechanism by which crosstalk with other signaling pathways is achieved. Crucial effector components of the ubiquitination cascade include the very diverse family of E3 ubiquitin ligases. This review summarizes the diverse roles of E3 ligases that act on TGFβ receptor and intracellular signaling components.
    [Show full text]
  • Smurf2-Mediated Stabilization of DNA Topoisomerase Iiα Controls Genomic Integrity
    Published OnlineFirst June 13, 2017; DOI: 10.1158/0008-5472.CAN-16-2828 Cancer Molecular and Cellular Pathobiology Research Smurf2-Mediated Stabilization of DNA Topoisomerase IIa Controls Genomic Integrity Andrea Emanuelli1, Aurora P. Borroni1, Liat Apel-Sarid2, Pooja A. Shah1, Dhanoop Manikoth Ayyathan1, Praveen Koganti1, Gal Levy-Cohen1, and Michael Blank1 Abstract DNA topoisomerase IIa (Topo IIa) ensures genomic integ- pathological chromatin bridges formed during mitosis, a trait rity and unaltered chromosome inheritance and serves as a of Topo IIa–deficient cells and a hallmark of chromosome major target of several anticancer drugs. Topo IIa function is instability. Introducing Topo IIa into Smurf2-depleted cells well understood, but how its expression is regulated remains rescued this phenomenon. Smurf2 was a determinant of Topo unclear. Here, we identify the E3 ubiquitin ligase Smurf2 as a IIa protein levels in normal and cancer cells and tissues, and its physiologic regulator of Topo IIa levels. Smurf2 physically levels affected cell sensitivity to the Topo II–targeting drug interacted with Topo IIa and modified its ubiquitination status etoposide. Our results identified Smurf2 as an essential regu- to protect Topo IIa from the proteasomal degradation in dose- lator of Topo IIa, providing novel insights into its control and catalytically dependent manners. Smurf2-depleted cells and into the suggested tumor-suppressor functions of Smurf2. exhibited a reduced ability to resolve DNA catenanes and Cancer Res; 77(16); 1–11. Ó2017 AACR. Introduction mice knockout for Smurf2 develop a wide spectrum of tumors in different organs and tissues. These and other studies estab- DNA topoisomerase IIa (Topo IIa) is the major form of the lished Smurf2 as an important regulator of genomic integrity, Topo II enzyme in cycling vertebrate cells that acts to untangle whose inactivation results in carcinogenesis (7).
    [Show full text]
  • Celastrol Increases Glucocerebrosidase Activity in Gaucher Disease by Modulating Molecular Chaperones
    Celastrol increases glucocerebrosidase activity in Gaucher disease by modulating molecular chaperones Chunzhang Yanga,1, Cody L. Swallowsa, Chao Zhanga, Jie Lua, Hongbin Xiaob, Roscoe O. Bradya,1, and Zhengping Zhuanga,1 aSurgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892-1260; and bInstitute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China Contributed by Roscoe O. Brady, November 19, 2013 (sent for review October 21, 2013) Gaucher disease is caused by mutations in the glucosidase, beta, acid increased the catalytic activity of mutant GCase. Celastrol interfered gene that encodes glucocerebrosidase (GCase). Glucosidase, beta, with the recruitment of Cdc37 to Hsp90 halting the assembly of the acid mutations often cause protein misfolding and quantitative loss requisite chaperone complex. Inhibition of Hsp90 reduced its rec- of GCase. In the present study, we found that celastrol, an herb de- ognition of mutant GCase and therefore limited the proteasomal rivative with known anticancer, anti-inflammatory, and antioxidant degradation of the mutant protein. Additionally, celastrol triggered activity, significantly increased the quantity and catalytic activity of a reorganization of the gene expression pattern of molecular chap- GCase. Celastrol interfered with the establishment of the heat-shock erones such as DnaJ homolog subfamily B members 1 and 9 protein 90/Hsp90 cochaperone Cdc37/Hsp90-Hsp70-organizing pro- (DNAJB1/9), heat shock 70kDa proteins 1A and 1B (HSPA1A/B), tein chaperone complex with mutant GCase and reduced heat-shock and Bcl2-associated athanogene 3 (BAG3). The presence of BAG protein 90-associated protein degradation. In addition, celastrol mod- family molecular chaperone regulator 3 (BAG3) further stabi- ulated the expression of molecular chaperones.
    [Show full text]